The proto-oncogene Bcl-2 and its role in regulating apoptosis (original) (raw)

References

1. Thompson, C.B. Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456–1462 (1995).
   Article CAS PubMed Google Scholar
2. Kroemer, G., Petit, P.X. Zamzami, N. Vayssière, J.-L. & Mignotte, B. The biochemistry of apoptosis. FASEB J. 9, 1277–1287 (1995).
   Article CAS PubMed Google Scholar
3. Reed, J.C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124, 1–6 (1994).
   Article CAS PubMed Google Scholar
4. Yang, E. & Korsmeyer, S.J. Molecular thanatopsis: A discourse on the Bcl-2 family and cell death. Blood 88, 386–401 (1996).
   CAS PubMed Google Scholar
5. Zoratti, M. & Szabd, I. The mitochondrial permeability transition. Biochim. Biophys. Ada – Rev. Biomembr. 1241, 139–176 (1996).
   Article Google Scholar
6. Kroemer, G., Zamzami, N. & Susin, S.A. Mitochondrial control of apoptosis. Immunol. Today 18, 44–51 (1997).
   Article CAS PubMed Google Scholar
7. Carayon, P. et al. Involvement of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical species. Blood 87, 3170–3178 (1996).
   CAS PubMed Google Scholar
8. Tanaka, S., Saito, K. & Reed, J.C. Structure-function analysis of the Bcl-2 oncoprotein: Addition of a heterologous transmembrane domain to portions of the Bcl-2p protein restores function as a regulator of cell survival. J. Biol. Chem. 268, 10920–10926 (1993).
   CAS PubMed Google Scholar
9. Hockenbery, D.M., Oltvai, Z.N., Yin, X.-M., Milliman, C.L. & Korsmeyer, S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241–251 (1993).
   Article CAS PubMed Google Scholar
10. Wang, H.-C., Rapp, U.R. & Reed, J. C. Bcl-2 targets the protein kinase raf-1 to mitochondria. Cell 87, 629–638 (1996).
    Article CAS PubMed Google Scholar
11. Wu, D., Wallen, H.D. & Nu–ez, C. Interaction and regulation of subcellular localization of CED-4 by CED-9. Science 275, 1126–1129 (1997).
    Article CAS PubMed Google Scholar
12. Zhu, W. Bcl-2 mutants with restricted subcellular localization reveal spatially distinct pathways for apoptosis in different cell types. EMBO J. 15, 4130–4141 (1996).
    Article CAS PubMed PubMed Central Google Scholar
13. Zha, H. et al. Structure-function comparisons of the pro-apoptotic protein Bax in yeast and mammalian cells. Mol. Cell. Biol. 16, 6494–6508 (1996).
    Article CAS PubMed PubMed Central Google Scholar
14. Chinnaiyan, A.M., O'Rourke, K., Lane, B.R. & Dixit, V.M. Interaction of CED-4 with CED-3 and CED-9: A molecular frame for cell death. Science 275, 1122–1126 (1997).
    Article CAS PubMed Google Scholar
15. Cheng, E.H.-Y., Levine, B., Boise, L.H., Thompson, C.B. & Hardwick, J.M. Bax-independent inhibition of apoptosis by Bcl-XL . Nature, 379, 554–556 (1996).
    Article CAS PubMed Google Scholar
16. Kane, D. J. et al. Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science 262, 1274–1277 (1993).
    Article CAS PubMed Google Scholar
17. Zha, H., Aime-Sempre, C., Sato, T. & Reed, J.C. Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J. Biol. Chem. 271, 7440–7444 (1996).
    Article CAS PubMed Google Scholar
18. Hunter, J.J. & Parslow, T.G. A peptide sequence from Bax that converts Bcl-2 into an activator of apoptosis. J. Biol. Chem. 271, 8521–8524 (1996).
    Article CAS PubMed Google Scholar
19. Sattler, M. Structure of Bcl-x(L)-Bak peptide complex: Recognition between regulators of apoptosis. Science 275, 983–986 (1997).
    Article CAS PubMed Google Scholar
20. Boyd, J.M. et al. (1995) Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 11, 1921–1928.
    CAS PubMed Google Scholar
21. Wang, K., Yin, X.M., Chao, D.T., Milliman, C.L. & Korsmeyer, S.J. BID: A novel BH3 domain-only death agonist. Genes & Development 10, 2859–2869 (1996).
    Article CAS Google Scholar
22. Hanada, M., Aimesempe, C., Sato, T. & Reed, J.C. Structure-function analysis of Bcl-2 protein identification of conserved domains important for homodimerization with Bcl-2 and heterodimerization with Bax J. Biol. Chem. 270, 11962–11969 (1995).
    Article CAS PubMed Google Scholar
23. Hunter, J.J., Bond, B.L. & Parslow, T.C. Functional dissection of the human Bcl2 protein: Sequence requirements for inhibition of apoptosis. Mol. Cell. Biol. 16, 877–883 (1996).
    Article CAS PubMed PubMed Central Google Scholar
24. Wang, H.G., Takayama, S., Rapp, U.R. & Reed, J.C. Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1. Proc. Natl. Acad. Sci. USA 93, 7063–7068 (1996).
    Article CAS PubMed PubMed Central Google Scholar
25. Shibasaki, F., Kondo, E., Akagi, T. & McKeon, F. Suppression of signalling through transcription factor NF-AT by interaction between calcineurin and Bcl-2. Nature 386, 728–731 (1996).
    Article Google Scholar
26. Strack, P.R. et al. Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2. Proc. Natl. Acad. Sci. USA 93, 9571–9576 (1996).
    Article CAS PubMed PubMed Central Google Scholar
27. Haldar, S., Chintapalli, J. & Croce, CM. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Research 56, 1253–1255 (1996).
    CAS PubMed Google Scholar
28. Uhlmann, E.J. et al. Deletion of a nonconserved region of Bcl-2 confers a novel gain of function: Suppression of apoptosis with concomitant cell proliferation. Cancer Res. 56, 2506–2509 (1996).
    CAS PubMed Google Scholar
29. Zha, J.P., Harada, H., Yang, E., Jockel, J. & Korsmeyer, S.J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BGL-X(L). Cell 87, 619–628 (1996).
    Article CAS PubMed Google Scholar
30. Bardelli, A. et al. HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death. EMBO Journal 15, 6205–6212 (1996).
    Article CAS PubMed PubMed Central Google Scholar
31. Muchmore, S.W. et al. X-ray and NMR structure of human Bcl-XL, and inhibitor of programmed cell death. Nature 381, 335–341 (1996).
    Article CAS PubMed Google Scholar
32. Minn, A.J. et al. Bcl-XL form an ion channel in synthetic lipid membranes. Nature 385, 353–357 (1997).
    Article CAS PubMed Google Scholar
33. Lam, M. et al. Evidence that BCL-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes. Proc. Natl. Acad. Sci. USA 85, 6569–6573 (1994).
    Article Google Scholar
34. Marin, M.C. et al. Apoptosis suppression by bcl-2 is correlated with the regulation of nuclear and cytosolic Ca2+. Oncogene 12, 2259–2266 (1996).
    CAS PubMed Google Scholar
35. Baffy, G., Miyashati, T., Williamson, J.R. & Reed, J.C. Apoptosis induced by withdrawal of interleukin-3 (IL-3) dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncogene production. J. Biol. Chem. 268, 6511–6519 (1993).
    CAS PubMed Google Scholar
36. Murphy, A.N., Bredesen, D.E., Cortopassi, G., Wang, E. & Fiskum, G. Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc. Natl. Acad. Sci. USA 93, 9893–9898 (1996).
    Article CAS PubMed PubMed Central Google Scholar
37. Reynolds, J.E. & Eastman, A. Intracellular calcium stores are not required for Bcl-2-mediated protection from apoptosis. J. Biol. Chem. 271, 27739–27743 (1996).
    Article CAS PubMed Google Scholar
38. Chinnaiyan, A.M. et al. Molecular ordering of the cell death pathway — Bcl-2 and Bcl-X(L) function upstream of the CED-3-like apoptotic proteases. J. Biol. Chem. 271, 4573–4576 (1996).
    Article CAS PubMed Google Scholar
39. Zamzami, N. et al. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182, 367–377 (1995).
    Article CAS PubMed Google Scholar
40. Liu, X., Kim, C.N., Yang, J., Jemmerson, R. & Wang, X. Induction of apoptic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 86, 147–157 (1996).
    Article CAS PubMed Google Scholar
41. Yang, J. et al. Prevention of apoptosis by Bcl-2: Release of cytochrome cfrom mitochondria blocked. Science 275, 1129–1132 (1997).
    Article CAS PubMed Google Scholar
42. Kluck, R.M., Bossy-Wetzel, E., Green, D.R. & Newmeyer, D.D. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 275,,1132–1136 (1997).
    Article CAS PubMed Google Scholar
43. Zamzami, N. et al. Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183, 1533–1544 (1996).
    Article CAS PubMed Google Scholar
44. Shimizu, S. et al. Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene 13, 21–29. (1996).
    CAS PubMed Google Scholar
45. Kantrow, S.P. & Piantadosi, C.A. Release of cytochrome cfrom liver mitochondria during permeability transition. Biochem. Biophys. Res. Commun. 232, 669–671 (1997).
    Article CAS Google Scholar
46. Xiang, J., Chao, D.T. & Korsmeyer, S.J. Bax-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA 93, 14559–14563 (1996).
    Article CAS PubMed PubMed Central Google Scholar
47. Shimizu, S. et al. Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-XL. Nature 374, 811–813 (1995).
    Article CAS PubMed Google Scholar
48. Newmeyer, D.D., Farschon, D.M. & Reed, C. Cell-free apoptosis in Xenopus egg extracts: Inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria. Cell 79, 353––364 (1994).
    Article CAS PubMed Google Scholar
49. Susin, S.A. et al. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 84, 1331–1342 (1996).
    Article Google Scholar
50. Weil, M. et al. Constitutive expression of the machinery for programmed cell death. J. Cell Biol. 133, 1053–1059 (1996).
    Article CAS PubMed Google Scholar
51. Martinou, J.C. et al. Overexpression of Bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13, 1017–1030 (1994).
    Article CAS PubMed Google Scholar
52. Chen, D.F., Schneider, G.E., Martinou, J.-C. & Tonegawa, S. Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature 385, 434–439 (1997).
    Article CAS PubMed Google Scholar
53. Lawrence, M.S., Ho, D.Y., Sun, G.H., Steinberg, G.K. & Sapolsky, R.M. Over-expression of bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J. Neurosci. 16, 486–496 (1996).
    Article CAS PubMed PubMed Central Google Scholar
54. McCarthy, N.J., Whyte, M. K.B., Gilbert, C.S. & Evan, G.I. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J. Cell Biol. 136, 215–227 (1997).
    Article CAS PubMed PubMed Central Google Scholar
55. Strobel, T., Swanson, L., Korsmeyer, S. & Cannistra, S.A. BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway. Proc. Natl. Acad. Sci. USA 93, 14094–14099 (1996).
    Article CAS PubMed PubMed Central Google Scholar
56. Brady, H.J.M., Salomons, G.S., Bobeldijk, R.C. & Berns, A.J.M. T cells from bax alpha transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA damage-induced cell death in the absence of p53. EMBO J. 15, 1221–1230 (1996).
    Article CAS PubMed PubMed Central Google Scholar
57. Huang, D.C.S., Cory, S. & Strasser, A. Bcl-2, Bcl-XL, and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Oncogene 14, 405–414 (1997).
    Article CAS PubMed Google Scholar
58. Evtodienki, Y.V., Teplova, V.V., Sidashi, S.S., Ichas, F. & Mazat, J.-P. Microtubule-active drugs suppress the closure of the permeability transition pore in tumour mitochondria. FEBS Lett. 393, 86–88 (1996).
    Article Google Scholar
59. Jacobson, M.D., Burne, J.F. & Raff, M.C. Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J. 13, 1899–1910 (1994).
    Article CAS PubMed PubMed Central Google Scholar
60. Tsao, N. & Lei, H.Y. Activation of the Na+/H+ antiporter, Na+/HCO3−/CO32− cotrans-porter, or CI−/HCO3− exchanger in spontaneous thymocyte apoptosis. J. Immunol. 157, 1107–1116 (1996).
    CAS PubMed Google Scholar
61. Martin, S.J. et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182, 1545–1556 (1995).
    Article CAS PubMed Google Scholar
62. Ellerby, L.M. etal. Shift of the cellular oxidation-reduction potential in neural cells expressing bcl-2. J. Neurochem. 67, 1259–1267 (1996).
    Article CAS PubMed Google Scholar
63. Reynolds, J.E., Li, J.F., Craig, R.W. & Eastman, A. Bcl-2 and Mcl-1 expression in Chinese hamster ovary cells inhibits intracellular acidification and apoptosis induced by staurosporine. Exp. Cell Res. 225, 430–436 (1996).
    Article CAS PubMed Google Scholar
64. Hennet, T., Bertoni, G., Richter, C. & Peterhans, E. Expression of BCL-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity. Cancer Res. 53, 1456–1460 (1993).
    CAS PubMed Google Scholar

Download references